NCT05227508 - The Effect of BRIZO on Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hypertrophy (BPH) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

June 30, 2024

Conditions

BPH Without Urinary Obstruction and Other Lower Urinary Tract Symptoms (LUTS)

Interventions

DIETARY_SUPPLEMENT

BRIZO

A capsule containing 400 mg. SC012 (unique soy extract)

OTHER

placebo

Comprecel microcrystalline cellulose

Trial Locations (1)

RECRUITING

Rabin Medical Center - Clalit Health Services, Petah Tikva